| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.054 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |